BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210330T160000
DTEND;TZID=America/New_York:20210330T180000
DTSTAMP:20210225T161411Z
CREATED:20210225T161411Z
LAST-MODIFIED:20210225T161411Z
UID:48631-1617120000-1617127200@globalbiodefense.com
SUMMARY:How COVID-19 Pandemic Changes Medical Research\, Teaching and Patient Care
DESCRIPTION:A virtual presentation on “How COVID-19 Pandemic Changes Medical Research\, Teaching and Patient Care” will be held on March 20\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speaker \nEzekiel J. Emanuel is the Vice Provost for Global Initiatives\, the Diane v.S. Levy and Robert M. Levy University Professor\, and Co-Director of the Healthcare Transformation Institute at the University of Pennsylvania. From January 2009 to January 2011\, Dr. Emanuel served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. Prior to that he was the founding chair of the Department of Bioethics at the National Institutes of Health from 1997 to August of 2011. Dr. Emanuel received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. After completing his internship and residency in internal medicine at Boston’s Beth Israel Hospital and his oncology fellowship at the Dana-Farber Cancer Institute\, he joined the faculty at the Dana-Farber Cancer Institute. He has since been a visiting professor at the University of Pittsburgh School of Medicine\, UCLA\, the Brin Professor at Johns Hopkins Medical School\, and the Kovitz Professor at Stanford Medical School and visiting professor at New York University Law School. Dr. Emanuel served on President Clinton’s Health Care Task Force\, the National Bioethics Advisory Commission (NBAC)\, and on the bioethics panel of the Pan-American Healthcare Organization. He has published over 300 articles mainly on health care reform\, research ethics\, and end of life care. He has also authored or edited 15 books. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/how-covid-19-pandemic-changes-medical-research-teaching-and-patient-care/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41575
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210330T170000
DTEND;TZID=America/Los_Angeles:20210330T180000
DTSTAMP:20210223T212911Z
CREATED:20210223T212911Z
LAST-MODIFIED:20210223T212911Z
UID:48590-1617123600-1617127200@globalbiodefense.com
SUMMARY:Model Me This: COVID-19 Scientific Predictions and Where We Go From Here
DESCRIPTION:The Pacific Northwest National Laboratory will host a virtual Demystifying COVID Seminar Series event entitled\, “COVID-19 Scientific Predictions and Where We Go From Here” on March 30\, 2021. \nThe Pacific Northwest National Laboratory’s Community Science and Technology Seminar Series was launched to help the general public better understand and explore how science transforms our world. \nABOUT THE SPEAKER \nDr. Tim Scheibe is the lead scientist for PNNL’s River Corridor Scientific Focus Area project. He develops the scientific vision for multiscale and computational science within the Environmental Molecular Sciences Division and frequently offers a national perspective on future scientific and technological needs. He specializes in multiscale modeling\, including parameter estimation and mitigating uncertainty. \nRegister for the event here.
URL:https://globalbiodefense.com/event/model-me-this-covid-19-scientific-predictions-and-where-we-go-from-here/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://pnnl.zoomgov.com/webinar/register/WN_KH262WbnSJqKRCe_u1bCJQ
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210407T183000
DTEND;TZID=America/New_York:20210407T200000
DTSTAMP:20240118T180225Z
CREATED:20210308T082324Z
LAST-MODIFIED:20240118T180225Z
UID:48783-1617820200-1617825600@globalbiodefense.com
SUMMARY:Schar School of Policy and Government: Master’s and Certificate Virtual Open House
DESCRIPTION:Master’s and Certificate Virtual Open House\nApril 7\, 2021 6:30 p.m. – 8:00 p.m. ET \nLearn more about the Schar School of Policy and Government and our academic programs at a virtual open house. The online session will provide an overview of our master’s degree and graduate certificate programs\, student services\, and admissions requirements. \nLearn more: http://bit.ly/scharopenhouse2021
URL:https://globalbiodefense.com/event/schar-school-of-policy-and-government-masters-and-certificate-virtual-open-house/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2021/03/gmu-schar-school-open-house-large-1200.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210422
DTSTAMP:20210227T184218Z
CREATED:20210227T184218Z
LAST-MODIFIED:20210227T184218Z
UID:48698-1618876800-1619049599@globalbiodefense.com
SUMMARY:APBI 2021 - APG Advanced Planning Briefing to Industry
DESCRIPTION:Team Aberdeen Proving Ground (APG) is hosting the APG Advanced Planning Briefing to Industry (APBI) on April 20-21\, 2021 via virtual format. \nThe goal of the APG APBI is to describe for industry potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. \nAdditional details will be posted at beta.SAM.gov as updates become available.
URL:https://globalbiodefense.com/event/apbi-2021-apg-advanced-planning-briefing-to-industry/
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210504T160000
DTEND;TZID=America/Los_Angeles:20210504T180000
DTSTAMP:20240623T231246Z
CREATED:20210225T161815Z
LAST-MODIFIED:20240623T231246Z
UID:48633-1620144000-1620151200@globalbiodefense.com
SUMMARY:Reporting Science to Public & How 'Science' Adapts to the Pandemic
DESCRIPTION:A virtual presentation on “Reporting Science to Public & How ‘Science’ Adapts to the Pandemic” will be held on May 4\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \n~ Stephen Smith (Washington Post Health and Science Editor) \n~ Valda Vinson\, PhD (Science Editor) – Valda Vinson is Editor (Research) at Science. She came to the United States as a Fulbright scholar and after completing a Ph.D and post-doctoral studies\, spent 2 years as a Senior Lecturer at the University of the Western Cape. She started her career in publishing when she joined the Science staff in 1999. Since then\, she has handled research papers in the areas of structural biology\, biochemistry\, and biophysics as an Associate and Senior Editor. In 2013 Dr. Vinson became Deputy Editor\, overseeing research content in the areas of cellular and molecular biology and biomedicine\, and in 2018 was named Editor\, Research. As Editor she works with Life Science editors to attract and select exciting research papers and reviews\, while following standards that support transparency and reproducibility. She also works with others on the editorial management team on editorial policies at Science and is involved in initiatives that bring together stake-holders within the publishing industry to discuss policies. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/reporting-science-to-public-how-science-adapts-to-the-pandemic/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210511T110000
DTEND;TZID=America/New_York:20210511T150000
DTSTAMP:20201127T193923Z
CREATED:20201127T193923Z
LAST-MODIFIED:20201127T193923Z
UID:48065-1620730800-1620745200@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030 - Session 4
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on May 11\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will consider ways the thoughtful and deliberate use of new technologies could improve the clinical trials enterprise and support goals outline in prior webinar sessions. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. \nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will plan and conduct a virtual public workshop designed to consider a transformed clinical trial enterprise for 2030. Key priority challenges and opportunities framing the 2030 agenda are: \n\nDiversity and inclusion of clinical trial participants\nConvergence of clinical research and clinical practice\nClinical trial data sharing\nIncorporation of new technologies into drug research and development\nWorkforce and career development\nPublic engagement and partnership\nRegulatory Environment\nCultural and Financial Incentives\nPractical short- and long-term goals for improving the efficiency\, effectiveness\, person-centeredness\, inclusivity\, and integration with healthcare of the clinical trials enterprise.\n\nPlanning Committee\n\nSteven Galson (Co-Chair)\, Amgen\nEster Krofah (Co-Chair)\, FasterCures\, Milken Institute\nAmy Abernethy\, Office of the Comissioner\, FDA\nAnita LaFrance Allen\, University of Pennsylvania\nChristopher P. Austin\, National Center for Advancing Translational Sciences\, NIH\nHoward A. Burris\, Sarah Cannon\nLuther T. Clark\, Merck & Co.\, Inc.\nGiselle Corbie-Smith\, The University of North Carolina at Chapel Hill\nM. Khair ElZarrad\, Center for Drug Evaluation and Research\, FDA\nJennifer Goldsack\, Digital Medicine Society\nRichard A. Moscicki\, PhRMA\nAmy Patterson\, National Heart\, Lung\, and Blood Institute\, NIH\nJoseph Scheeren\, Critical Path Institute\nAnantha Shekhar\, University of Pittsburgh\nPamela Tenaerts\, Clinical Trials Transformation Initiative\nChristopher Yoo\, Systems Oncology\n\nFor additional information on the workshop series\, please visit the project page.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030-session-4/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://bit.ly/nasem-clinicaltrialenterprise
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210518
DTEND;VALUE=DATE:20210519
DTSTAMP:20210518T222659Z
CREATED:20210318T222200Z
LAST-MODIFIED:20210518T222659Z
UID:49251-1621296000-1621382399@globalbiodefense.com
SUMMARY:CBRNE Research and Innovation 2021
DESCRIPTION:The International e-Conference on CBRNE Research & Innovation will take place May 18\, 2021. \nHighlighted topics include: \n\nRecycling protective garments processes and techniques used for decontaminating and removing unwanted organic substances\nOnline tools for assessment of factors associated with SARS-CoV-2 infection\, and evaluation of new prophylactic and therapeutic drug regimens against COVID-19\nDiscovery tools in preparedness and response to NRBC threats\nPReparedness against CBRNE threats through cOmmon Approaches between security praCTItioners and the VulnerablE civil society (PROACTIVE)\nEuropean Network of CBRN Training Centers: just-in-time training and evolving training methodologies for first responders\n\nThe virtual format event builds on the success of the first 3 international conferences which tool place in Antibes (2015)\, Lyon (2017) and Nantes (2019) and will serve as a professional bridge until the next in-person conference at Lille in May 2022. \nhttps://cbrneconference.fr/ \n  \n 
URL:https://globalbiodefense.com/event/cbrne-research-and-innovation-2021/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://cbrneconference.fr/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210520T090000
DTEND;TZID=America/New_York:20210520T110000
DTSTAMP:20210520T140902Z
CREATED:20210501T140556Z
LAST-MODIFIED:20210520T140902Z
UID:49256-1621501200-1621508400@globalbiodefense.com
SUMMARY:The Future of Global Health Security
DESCRIPTION:Join Dr. Tom Frieden and the Prevent Epidemics team of Resolve to Save Lives\, an initiative of Vital Strategies\, to discuss lessons from past outbreaks\, preparedness successes\, and the need to invest and prioritize funding to fight the next pandemic. The event will call on political and public health leaders to increase global collaboration and work together at the global\, regional\, country\, and local levels to build a more resilient response to future health emergencies. For more information pandemic preparedness\, read our recent report Epidemics that Didn’t Happen.
URL:https://globalbiodefense.com/event/the-future-of-global-health-security/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://preventepidemics.org/globalhealthsecurityevent/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20210527T133000
DTEND;TZID=Europe/Paris:20210527T144500
DTSTAMP:20210518T223618Z
CREATED:20210501T222833Z
LAST-MODIFIED:20210518T223618Z
UID:49253-1622122200-1622126700@globalbiodefense.com
SUMMARY:Advancing Gender Perspectives in the Biological Weapons Convention
DESCRIPTION:The International Gender Champions Disarmament Impact Group and the BWC Implementation Support Unit welcome you to an interactive discussion on 27 May on the relevance of gender perspectives to the implementation of the Biological Weapons Convention. \nThe discussion will address recent initiatives to improve women’s meaningful participation in the BWC\, as well as research on sex-specific and gendered impacts of biological weapons. \nPanelists will take stock of how gender perspectives are already being incorporated into BWC discussions and\, in view of the forthcoming Ninth BWC Review Conference\, how they can be further promoted and strengthened in future BWC work programmes. \nThe event will also mark the launch of a new factsheet by the Disarmament Impact Group on “Gender and Biological Weapons”. \n 
URL:https://globalbiodefense.com/event/advancing-gender-perspectives-in-the-biological-weapons-convention/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://rtce-unog.webex.com/mw3300/mywebex/default.do?nomenu=true&siteurl=rtce-unog&service=6&rnd=0.4655756273962446&main_url=https%3A%2F%2Frtce-unog.webex.com%2Fec3300%2Feventcenter%2Fevent%2FeventAction.do%3FtheAction%3Ddetail%26%26%26EMK%3D4832534b00000004346873833f32d707b10d18ee70fc3d5c8c3d215ec63e9ede0c9f7e79edd173a2%26siteurl%3Drtce-unog%26confViewID%3D194014003524017497%26encryptTicket%3DSDJTSwAAAAQm5DyOP2TNxCQgIiR4ZmkiGlbFK2NrgnXV1zaYNmQKdw2%26
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210527T153000
DTEND;TZID=Europe/London:20210527T163000
DTSTAMP:20210518T201503Z
CREATED:20210518T201503Z
LAST-MODIFIED:20210518T201503Z
UID:49248-1622129400-1622133000@globalbiodefense.com
SUMMARY:Maximum Containment Labs Around the World
DESCRIPTION:Join Dr. Filippa Lentzos and Dr. Gregory D. Koblentz for a briefing on 27 May 2021 on a new resource on global BSL4 labs and biorisk management policies. \nThis public webinar\, held on the side lines of the seventy-fourth World Health Assembly meeting\, will launch globalbiolabs.org\, an interactive web-based map of global Biosafety Level-4 facilities and biorisk management policies. An accompanying policy brief\, entitled ‘Mapping Maximum Biological Containment Labs Globally’\, will also be released. \n 
URL:https://globalbiodefense.com/event/maximum-containment-labs-around-the-world/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://us02web.zoom.us/webinar/register/WN_HuZbZ7SbS8OvljyRYr9-nA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210608
DTEND;VALUE=DATE:20210610
DTSTAMP:20210124T013522Z
CREATED:20210124T013522Z
LAST-MODIFIED:20210124T013522Z
UID:48301-1623110400-1623283199@globalbiodefense.com
SUMMARY:Pivotal Interfaces of Environmental Health and Infectious Disease Research to Inform Responses to Outbreaks
DESCRIPTION:This workshop will explore how environmental health tools\, technologies\, and methodologies can be leveraged to inform real-time public health decision making about infectious disease outbreaks\, epidemics\, and pandemics. The workshop may feature several case studies of infectious disease outbreaks for which spread and exposure is mediated\, in part\, by environmental pollution and conditions. \nAn ad hoc planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and convene a workshop to explore how environmental health tools\, technologies\, and methodologies can be leveraged to inform real-time public health decision making about infectious disease outbreaks\, epidemics\, and pandemics. The workshop may feature several case studies of infectious disease outbreaks for which spread and exposure is mediated\, in part\, by environmental pollution and conditions\, through the following questions: \n1) How can advances in environmental exposure assessment be applied to identify\, predict\, or monitor critical pathways by which humans are exposed to infectious agents? \n2)  How can recent advances in climate and environmental health modeling techniques be applied to better understand the biology of pathogens\, vectors\, and hosts; predict transmission dynamics; and provide early warning of emerging infectious diseases? \n3) How can environmental pollutants exposure models and data integration approaches be leveraged to predict population vulnerability/risk to infection? \n4) How sensitive is the initial emergence of infectious disease outbreaks to variations in environmental conditions? \nThe presentations and discussions at the workshop will be documented in a workshop proceedings\, written by a designated rapporteur in accordance with institutional guidelines.
URL:https://globalbiodefense.com/event/pivotal-interfaces-of-environmental-health-and-infectious-disease-research-to-inform-responses-to-outbreaks/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210707
DTEND;VALUE=DATE:20210710
DTSTAMP:20210226T214129Z
CREATED:20210226T214129Z
LAST-MODIFIED:20210226T214129Z
UID:48691-1625616000-1625875199@globalbiodefense.com
SUMMARY:New Approaches and Concepts in Microbiology
DESCRIPTION:The New Approaches and Concepts in Microbiology will take place 7-9 July 2021 in a virtual format. \nThe event will cover a broad range of topics in microbiology\, including antibiotic-related research\, bacterial communities and microbiome\, cell biology\, regulation & signalling\, pathogenesis and evolution. Emphasis will be placed on novel approaches and technologies (from systems-based to single-cell) that drive each field or have the potential to revolutionise future research in microbiology. \nThis must-attend event for scientists working with bacteria and new technologies. The focus remains on the interface of new technologies and new biology in bacteria\, but the thematic areas change and speaker line-ups do not overlap between consecutive symposia. \nThis symposium aims at bridging the gap between traditional microbiology and novel technologies\, by exposing microbiologists to new ways of addressing their hypotheses. At the same time\, it provides a platform for systems or technology experts to get a better understanding of the important questions in the field. \nHighlighted sessions and focus areas include:\nBacterial systems biology\nCell biology and protein machineries\nRegulation\, signalling and transcriptional networks\nPathogenesis and infection\nAntibiotic action-resistance-persistance\nMicrobial communities / microbiotas / symbiosis\nEvolution and ecology \nPlease visit EMBO | EMBL’s New Approaches and Concepts in Microbiology page for more information.
URL:https://globalbiodefense.com/event/new-approaches-and-concepts-in-microbiology/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210924T080000
DTEND;TZID=America/Los_Angeles:20210924T170000
DTSTAMP:20210924T220010Z
CREATED:20210924T215927Z
LAST-MODIFIED:20210924T220010Z
UID:49782-1632470400-1632502800@globalbiodefense.com
SUMMARY:ASHG 2021 - American Society of Human Genetics
DESCRIPTION:The annual meeting of the American Society of Human Genetics will convene in a virtual format 12-14 October 2021. \nWith over 7\,000 expected attendees\, the ASHG 2021 Virtual Meeting is a diverse\, global community that engages and welcomes diverse voices and alliances among scientists of all nationalities. \nHighlighted posters or presentations include: \n\nBuilding Genomic Data Science Capacity for Health Discovery and Innovation in Africa\nBenefits of Hybrid Capture for Viral Surveillance of SARS-CoV-2\nEmerging public policy and perspectives on biometrics (including DNA and facial imaging) in the US\nDownregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children\nUsing metagenomics to assess global levels of antimicrobial resistance\nHLA Fine Mapping and Genetic Risk Factors in Tuberculosis\nGenotype-by-infection interactions: Single cell RNASeq profiling of in-vivo host immune response to malaria reveals cell type and infection-specific eQTLs\nHigh-resolution genomic architecture of COVID-19 severe disease using multi-ethnic whole genome sequencing data\nA comprehensive repository of clinical\, lab assay\, and genetic data for studies of innate and adaptive immune responses during acute COVID-19 infection and convalescence\nCodon bias analysis of wildtype SARS-CoV-2 and prevalent variants indicates a mutational trajectory independent of human pulmonary tissue and genomic bias\nCommon and rare variant analyses combined with single-cell multiomics reveal cell-type-specific molecular mechanisms of COVID-19 severity\nIdentification of causal genetic variants in invasive pneumococcal diseases by exome analysis in children\nAnalysis of genetic variants of SARS-CoV-2 host factors ACE2\, NRP1\, TMPRSS2\, and FURIN in Japanese population from IRUD whole-exome sequencing data\nThe long-term effect of SARS-CoV-2 infection on host genetic regulation\nA computational approach for detecting physiological homogeneity in the midst of genetic heterogeneity\nA genome-wide association study identifies two novel loci for respiratory infection with Pseudomonas aeruginosa\nData-driven analysis exploring age and sex effects on gene expression for dengue hemorrhagic fever\nAssessing the potential correlation of polymorphisms in the IL6R gene with relative IL-6 elevation in severely ill COVID-19 patients\nAssociation of CXCR6 with COVID-19 severity: host genetic factors underlying transcriptomic regulation in 3p21.31 locus\n\nThe conference offers: \n\n16 Plenary abstract talks (abstract-driven)\n198 Platform talks (abstract-driven)\n16 Invited sessions (member proposed sessions)\n80 rapid-fire poster talks selected from the top scoring posters\nAlmost 2000 dynamic posters (abstract-driven) with a dedicated time slot on Monday\, October 18 for author presentations and interactions\nThe Presidential Symposium and a late breaking abstract-driven plenary session\nEnhanced capabilities for virtual networking through video and chat channels\nOpportunities for collaboration with an interdisciplinary network of emerging and leading scientists\nIndustry-driven technology solutions\nLive and on-demand content\nCEUs and CMEs available\n\nASHG is a global interdisciplinary community of 8\,000 researchers who investigate fundamental working of genes and genomic variation\, and who translate new genetic knowledge to propel biomedical research\, improve human health\, and understand our common ancestral origins. \nPlease visit the ASHG 2021 Meeting website for more information. \n 
URL:https://globalbiodefense.com/event/ashg-2021-american-society-of-human-genetics/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210925T080000
DTEND;TZID=America/Los_Angeles:20210925T170000
DTSTAMP:20210925T162800Z
CREATED:20210925T162800Z
LAST-MODIFIED:20210925T162800Z
UID:49841-1632556800-1632589200@globalbiodefense.com
SUMMARY:ABRCMS 2021 - Annual Biomedical Research Conference for Minority Students
DESCRIPTION:The Annual Biomedical Research Conference for Minority Students (ABRCMS)\, recipient of the 2019 AIMBE Excellence in STEM Education Award\, is one of the largest communities of underrepresented minorities in science\, technology\, engineering and mathematics. Students attend this conference to present their research\, enhance professional development skills\, explore graduate schools\, and network. Research faculty and program directors play an essential role in mentoring students and learning strategies for facilitating student success. \nLast year\, ABRCMS engaged nearly 4000 attendees through scientific and professional development sessions\, student presentations and networking opportunities. This year\, ABRCMS: The Virtual Experience will deliver timely and relevant content and activities tailored to the current times. You can expect the same ABRCMS conference you have come to love – with opportunities to learn\, share and connect with peers and experts – in a socially distant format. \nPlease visit the ABRCMS 2021 website for more information.
URL:https://globalbiodefense.com/event/abrcms-2021-annual-biomedical-research-conference-for-minority-students/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210927T120000
DTEND;TZID=America/New_York:20210927T140000
DTSTAMP:20210924T003101Z
CREATED:20210906T002704Z
LAST-MODIFIED:20210924T003101Z
UID:49752-1632744000-1632751200@globalbiodefense.com
SUMMARY:Evolving Crisis Standards of Care and Ongoing Lessons from COVID-19
DESCRIPTION:COVID-19 has fundamentally challenged the delivery of health care services worldwide\, forcing difficult choices on health professionals and laying bare many preexisting health\, medical\, and public health sector frailties. This National Academies workshop series will re-explore previous IOM Crisis Standards of Care recommendations in light of ongoing lessons from the COVID-19 pandemic\, with a particular focus on disaster planning\, legal and equity considerations\, and staffing considerations. \nIn the first virtual workshop of the series\, expert panelists will specifically: \n\nRe-examine the definitions and recommendations first outlined in IOM’s 2009 “Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations: A Letter Report”\nRe-explore the framework described in IOM’s 2012 report “Crisis Standards of Care: A Systems Framework for Catastrophic Disaster Response”\nReflect on pre-COVID-19 “lessons learned”\, and discuss which have been confirmed and/or refuted by the ongoing COVID-19 crisis.\nReflect on the strengths and weaknesses of the CSC framework and activation/implementation guidance in light of our current experiences and challenges with COVID-19.\n\nConfirmed speakers include: \n\nMonica Peek\, MD\, MPH\, Professor of Medicine\, University of Chicago Medicine\nJennifer Piatt\, Deputy Director with the Network for Public Health Law’s Western Region Office\nMike Wargo\, VP for Preparedness & Emergency Operations\, HCA Healthcare’s enterprise\nAnuj Mehta MD\, MD\, Assistant Professor\, University of Colorado\nDan Hanfling\, MD\, Vice President\, Technical Staff\, In-Q-Tel\nCraig Vanderwagen\, MD\, Rear Admiral USPHS – retired\, founding Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services\, and Founder and General Manager of East West Protection\, LLC\n\nPlease visit the National Academies’ Evolving Crisis Standards of Care and Ongoing Lessons from COVID-19 event website for more information.
URL:https://globalbiodefense.com/event/evolving-crisis-standards-of-care-and-ongoing-lessons-from-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210928T090000
DTEND;TZID=America/New_York:20210928T103000
DTSTAMP:20210925T165652Z
CREATED:20210925T165502Z
LAST-MODIFIED:20210925T165652Z
UID:49848-1632819600-1632825000@globalbiodefense.com
SUMMARY:Launch of the Defeating Meningitis by 2030 Roadmap
DESCRIPTION:The impact of meningitis is as profound as it is diverse: it can kill within hours\, disrupts health\nsystems\, impedes education and child development\, devastates families and communities\, and causes\nlifelong disabilities. Meningitis epidemics are unpredictable and can strike anywhere\, affecting people\nof any age\, including healthy children and young adults. \nDespite successful efforts to control meningitis in several regions\, meningitis continues to be a major public health issue. It kills about 250 000 people annually\, and leaves 1 in 5 of those affected with long-term devastating sequelae. \nDr Tedros Adhanom Ghebreyesus\, Director-General of the World Health Organization and partners will be launching Defeating Meningitis by 2030: A Global Road Map on: Tuesday\, 28 September 2021.   \nThe meningitis road map—developed though a robust\, multidisciplinary consultation process—\nrepresents an unprecedented opportunity to channel the wave of “defeat meningitis” momentum\ninto a concrete plan of action. Defeating meningitis is not only feasible\, but also critical to the\nachievement of the Sustainable Development Goals (SDGs) and will strengthen many aspects of the\nhealth system – from disease surveillance\, to immunization\, to primary health care and universal\nhealth coverage\, to improving services for persons living with disabilities. \nImplementing the road map is how the global community will come together to defeat meningitis. The five pillars of the road map each address a critical need in the fight against meningitis: prevention and epidemic control\, prompt diagnosis and treatment\, disease surveillance\, support and care for people (and families) affected by meningitis\, and advocacy and engagement. How do we leverage the road map to facilitate impact? This panel will share some of the major strides we have already made and provide a view on what the future holds. \nPlease visit the WHO’s Launch of the Defeating Meningitis Roadmap website for more information
URL:https://globalbiodefense.com/event/launch-of-the-defeating-meningitis-by-2030-roadmap/
CATEGORIES:Awareness Event,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/world-health-defeating-meningitis-global-road-map.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210928T110000
DTEND;TZID=America/New_York:20210928T130000
DTSTAMP:20210925T183006Z
CREATED:20210915T181953Z
LAST-MODIFIED:20210925T183006Z
UID:49861-1632826800-1632834000@globalbiodefense.com
SUMMARY:National Biodefense Science Board Public Meeting
DESCRIPTION:The National Biodefense Science Board (NBSB) will convene to discuss the strategy and planning for the National Special Pathogen System and other high priority issues related to national public health emergency preparedness and response. \nThe meeting is open to the public and will be held in a virtual format on September 28\, 2021. The NBSB invites those who are involved in or represent a relevant industry\, academia\, health profession\, health care consumer organization\, or state\, Tribal\, territorial or local government to request up to seven minutes to address the board in person via Zoom. \nRequests to provide remarks to the NBSB during the public meeting may be sent to NBSB@hhs.gov. Please include the name of the speaker\, organization\, and a full explanation of the intended comments. Please submit your request by 5PM ET on September 24\, 2021. \nABOUT THE NBSB \nThe National Biodefense Science Board (NBSB or the Board) is authorized under Section 319M of the Public Health Service (PHS) Act\, as added by Section 402 of the Pandemic and All-Hazards Preparedness Act of 2006 and amended by Section 404 of the Pandemic and All-Hazards Preparedness Reauthorization Act. The Board is governed by the Federal Advisory Committee Act\, which sets forth standards for the formation and use of advisory committees. The NBSB provides expert advice and guidance on scientific\, technical\, and other matters of special interest to the Department regarding current and future chemical\, biological\, nuclear\, and radiological agents\, whether naturally occurring\, accidental\, or deliberate. \nMembers of the public may attend the meeting via a toll-free phone number or Zoom teleconference\, which requires pre-registration. The meeting link to pre-register will be posted on https://www.phe.gov/​nbsb. Members of the public may provide written comments or submit questions for consideration by the NBSB at any time via email to NBSB@hhs.gov. Members of the public are also encouraged to provide comments after the meeting.
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting-2/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210929
DTEND;VALUE=DATE:20211004
DTSTAMP:20210925T051605Z
CREATED:20210925T051605Z
LAST-MODIFIED:20210925T051605Z
UID:49818-1632873600-1633305599@globalbiodefense.com
SUMMARY:IDWeek 2021 - Infectious Diseases Society of America
DESCRIPTION:IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA)\, Society for Healthcare Epidemiology of America (SHEA)\, the HIV Medicine Association (HIVMA)\, the Pediatric Infectious Diseases Society (PIDS)\, and the Society of Infectious Diseases Pharmacists (SIDP). \nIDWeek 2021 takes place virtually from Sept. 29-Oct. 3. IDWeek and its partners will again be joined with other scientific agencies\, non-governmental agencies\, and infectious diseases organizations around the world. Each will bring unique global perspectives and updated information on various aspects of COVID-19. \nHighlighted presentations and panels include: \n\nA Day with the Stewardship Pager – Challenging Stewardship Cases\nGenomics for Emerging (Zoonotic) viral diseases\nPicornaviruses: Beyond Hand\, Foot and Mouth Disease\nResuscitating Antimicrobial Stewardship and Healthcare Epidemiology Post-COVID\nChallenging Cases In Travel & Tropical Medicine\nSay It Don’t Spray It: Examining the Perspectives on Aerosols and Virus Transmission\nThe Tiny but Fierce Beasts of COVID-19 & Healthcare Epidemiology – Controversies in Pediatric Infection Prevention\nWhat’s Hot in Innovative Microbiological Diagnostics\nOptimizing Molecular Testing in Algorithms for the Diagnosis of Challenging Fungal Pathogens\nUnwanted guests: when fungi complicate patient care\nPCRs\, Presenteeism and PPE: Infection Prevention Post-COVID\nPotpourri: the vaccines I did not hear about during the pandemic\nTackling Antibiotic Resistance and Healthcare-associated Infections Around the Globe: Prevention and Surveillance Strategies\nInfectious Disease Consulting for Businesses During COVID-19: Tales from the Front Line\nA Day with the Hospital Epidemiologist’s Pager: Challenging Cases in Infection Prevention\nClimate Change\, Environmental Degradation and Infectious Diseases\nHomelessness and Infectious Diseases\nUpdates on Malaria Globally\nBurnout in Healthcare Epidemiology\nInfluencing Antibiotic Stewardship Activities—The Devil is in the Details\n\nPlease visit the IDWeek 2021 website for more information.
URL:https://globalbiodefense.com/event/idweek-2021-infectious-diseases-society-of-america/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210929T080000
DTEND;TZID=America/New_York:20210929T100000
DTSTAMP:20210925T153645Z
CREATED:20210911T152019Z
LAST-MODIFIED:20210925T153645Z
UID:49822-1632902400-1632909600@globalbiodefense.com
SUMMARY:Safeguarding and Advancing SRHR in Universal Health Coverage: On the Road to the 2023 UN High-Level Meeting on UHC
DESCRIPTION:Anti-gender movements and the COVID-19 pandemic have deepened existing challenges to realizing sexual and reproductive health and rights (SRHR). Universal health coverage can help overcome these barriers\, but only with an intersectional lens that centers girls and women in all their identities. The discussion will highlight why strengthened prioritization of SRHR must happen now\, as the foundation is being laid for the 2023 UN High-Level Meeting on Universal Health Coverage. \nThis is a virtual UNGA 76 side event hosted by the Alliance for Gender Equality and UHC \nInterpretation in English\, French\, and Spanish; auto closed-captioning in English. \nMichelle Remme (Moderator)\nDeputy Director @United Nations University International Institute for Global Health\n@DrMichelleRemme Dr. Michelle Remme (she/her) is Deputy Director at the United Nations University International Institute for Global Health\, where she leads the Gender and Health Hub. She is a health economist with over fifteen years of experience as a researcher and policy advisor in global health\, having worked in academia\, the UN system\, donor development cooperation and private consulting. Prior to joining UNU\, she served as Assistant Professor in Health Economics at the London School of Hygiene and Tropical Medicine. She conducts research and provides policy advice on topics related to the economics and financing of health programmes\, health systems and gender-responsive health interventions. \nHelen Clark\nFormer Prime Minister of New Zealand; Women Deliver Board Member @Women Deliver \n@HelenClarkNZ Helen Clark (she/her) was Prime Minister of New Zealand from 1999–2008. As Prime Minister\, and as a Member of Parliament over 27 years\, Helen engaged widely in policy development and advocacy across the international\, economic\, social\, environmental\, and cultural spheres. She advocated strongly for New Zealand’s comprehensive program on sustainability and for tackling the problems of climate change. She was an active leader of her country’s foreign relations\, engaging in a wide range of international issues. Helen was Administrator of the United Nations Development Programme from 2009-2017\, where she led UNDP to be ranked the most transparent global development organisation. She was also Chair of the United Nations Development Group. Helen continues to be a strong voice for sustainable development\, climate action\, gender equality and women’s leadership\, peace and justice\, and action on non-communicable diseases and on HIV. \nDumiso (Dumi) Gatsha\nFounder/Advisory Group Member @Success Capital Organisation/Civil Society Engagement Mechanism for UHC2030 (CSEM) \n@ProSuccessBW Dumiso (Dumi) Gatsha (they/them) is a proudly Pan African and unequivocally non-binary queer feminist working on eliminating the barriers between grassroots experiences and global policymaking. Dumi is the Founder of Success Capital Organisation\, a queer\, youth\, feminist-led\, managed and serving grassroots organisation working within Botswana’s community health system on HIV\, SRHR\, and GBV responses. In particular\, Dumi campaigns for period dignity\, safe abortion and socioeconomic equity beyond binaries. Dumi has previously consulted with V-Dem Institute\, Botswana Council of NGOs\, UNDP Botswana and CIVICUS World Alliance\, among others. Dumi is an advisory group member of the Civil Society Engagement Mechanism for UHC2030 (CSEM)\, Member of the African Queer Youth Initiative\, International Member Representative of Amnesty International\, and Vice Chair of Gender DynamiX (RSA)\, among other voluntary roles. \nVeloshnee Govender\nScientist\, Department of Sexual and Reproductive Health and Research @World Health Organization (WHO) \n@HRPresearch Veloshnee Govender (she/her) is a health economist with health policy and systems expertise in the Department of Sexual and Reproductive Health and Research (WHO\, Geneva). Veloshnee also holds an honorary senior lecturer post in the Health Economics Unit (University of Cape Town\, South Africa). Prior experiences include the Alliance for Health Policy and Systems Research (WHO\, Geneva)\, Health Economics Unit\, and Indian Institute of Management (Bangalore\, India). Her areas of work include health system strengthening and gender and equity issues in the context of sexual and reproductive health and rights and TB/HIV/AIDS. \nJagadishwor (Jagadish) Ghimire\nDeputy Country Director @Ipas Nepal \n@JagadishGhimre Jagadishwor (Jagadish) Ghimire (he/him) is a Development Practitioner in Nepal with 14+ years of experience in health systems focusing on sexual and reproductive health and rights. Jagadish holds a Master’s in Public Health (MPH) and Master of Arts in Sociology (MA)\, and is currently a MPhil Fellow in Population Studies. Jagadish is the Deputy Country Director for Ipas Nepal\, where he leads the implementation of project activities focusing on SRHR\, gender based violence prevention and response\, and climate justice and SRHR. Jagadish has also worked for UNFPA Nepal as a Family Planning Advisor\, CARE Nepal as Health Program Coordinator focusing on SRHR and GBV\, Family Planning Association of Nepal/IPPF as a Chief of Party for USAID’s Support for international Family Planning Organizations\, and with Population Services International (PSI) Nepal as Head of Program implementation\, among others. \nMilanya T. Jackline\nProgram Officer in charge of Community Empowerment @Kenya Female Advisory Organization (KEFEADO) \n@milanyakipusa Milanya T. Jackline (she/her) is an African feminist and is the Program Officer in charge of Community Empowerment at Kenya Female Advisory Organization (KEFEADO). Milanya is passionate about advocacy for gender equality\, reproductive health and rights\, and economic empowerment\, especially for adolescent girls and young women and including those with disabilities. She has been recognized by the East Africa Young Women Leadership Institute (EAYWLI) and is a trained facilitator on Looking in Looking Out (LILO) Sexual Identity and Human Right and on Sexuality and Spirituality under the Hearts Set of Pilgrimage Kenya Charter. She was part of the team that advocated for quality\, friendly and affordable SRHR health care services for the LGBTIQ in Migori and Kisumu in 2015. \nDr. Guna Nidhi Sharma\nSenior Health Administrator and Policy and Planning Section Chief @Government of Nepal\, Ministry of Health and Population \n@dr_gunish @mohpnep Dr. Guna Nidhi Sharma (he/him) (MPH\, Virije University\, Amsterdam\, the Netherlands\, and MBBS\, Tribhuvan University\, Institute of Medicine\, Maharajgunj Campus) is a Senior Health Administrator and the Policy and Planning Section Chief at the Nepal Ministry of Health and Population. He has engaged in formulation of the National Health Policy 2019\, the 15th Periodic Plan 2019-2023 and the Health Financing Strategy. He is a core technical team member at the ministry to respond COVID-19 pandemic and directly involved in developing more than 50 COVID-related strategic and technical documents. Dr. Guna’s main responsibilities are engaging in development of national level policies\, strategies and plans aligning with constitutional mandate and international commitments such as the SDGs. He has more than 16 years of experience in national and international organizations. Dr. Guna recently received a prestigious national award by the Right Honorable President of Nepal. \nSafeguarding and Advancing SRHR in Universal Health Coverage: On the Road to the 2023 UN High-Level Meeting on UHC \n  \n 
URL:https://globalbiodefense.com/event/safeguarding-and-advancing-srhr-in-universal-health-coverage-on-the-road-to-the-2023-un-high-level-meeting-on-uhc/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://globalhealth.org/event/safeguarding-and-advancing-srhr-in-universal-health-coverage-on-the-road-to-the-2023-un-high-level-meeting-on-uhc/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210929T120000
DTEND;TZID=America/New_York:20210929T153000
DTSTAMP:20210924T190915Z
CREATED:20210904T185727Z
LAST-MODIFIED:20210924T190915Z
UID:49763-1632916800-1632929400@globalbiodefense.com
SUMMARY:7th Annual Intelligence Community Academic Research Program
DESCRIPTION:The Intelligence Community Academic Research Symposium (ICARS) is the showcase for unclassified academic research supported by the Intelligence Community. \nThis event provides the opportunity for academic researchers\, advisors\, and members of the IC to exchange ideas and engage with fellow experts from diverse scientific backgrounds. Through integration and cooperation\, the IC Academic Research Symposium encourages innovation and collaboration between academia and the Intelligence Community. \nThis year’s participants and sponsors include: \n\nAir Force Institute of Technology\nFBI visiting scientist program\nIC Postdoctoral Research Fellowship Program\nNational Intelligence University\nNGA Academic Research Program\nThe Program on Extremism at George Washington University\nThe Cybersecurity Manufacturing Innovation Institute\nUK IC Postdoctoral Research Fellowship Programme\nUTSA’s National Security Collaboration Center\n\nHighlighted presentations include: \n\nMultiplex Aptamer Biosensors for the Standoff Detection of Nerve Agents\nMetapopulation Dynamics of Outbreaks and their Management\nImproving the Prediction of Hazardous Material Dispersion in an Urban Environment\nForecasting Dengue in Brazil at High Resolution\nLearning about the Geospatial Spread of Pathogens from their Genomes\nDevelopment of a Machine Learning Model to Predict Causes of Encephalitis\nUranium Isoscapes in Natural Waters: Factors Associated with Uranium Concentrations above 30 μg/Liter?\nAttribution of Explosives and Explosive Precursors\nEarly Detection of Chemical-Induced Temporal Stress Signatures in GMO and Non-GMO Maize\nIdentification of Illegal Manufacturing Activity via Wastewater Markers\nBenchmark Data Development to Classify Damage for Natural Disaster Relief Efforts\nNext Generation Cybersecure Architectures Enable U.S. Manufacturing Innovation\, Resilience\, and Productivity\nDeePRK – Measuring Human Performance of DNN-Assisted Object Search and Detection over North Korea\nAdaptive Infrared Thermal Signature Management\nBuilding an Urban Digital Twin: A Research Agenda\nSemantic Representations for Multi-Viewpoint Multimodal Geolocation\nLocalization and Planning for a UAV/Robot Team in Subterranean Environments\nGravity Portals: Quantum Sensors for Enhanced Border Screening\nLeveraging Environment and Culture to Anticipate Social Unrest with Integrated Model- and Data-Driven Approaches\nOptomechanical Sensing: Why So Sensitive?\nThe Impact of Explanations as Communicative Acts on Belief in a Claim: The Role of Source Reliability\n\nKEYNOTE SPEAKERS \nCatherine Marsh\, Ph.D. / Director\, Intelligence Advanced Research Projects Activity (IARPA)\nDr. Catherine Marsh became director of the Intelligence Advanced Research Projects Activity in November 2019 where she is responsible for investing in high-risk/high-payoff research that has the potential to provide our nation with an overwhelming intelligence advantage. Prior to this assignment\, Dr. Marsh was the chief scientist for the CIA’s Directorate of Science and Technology from 2016-2019\, where she was responsible for ensuring that leading-edge science and technology underlies current and future mission capabilities. Before that\, she served as the dean of the DS&T’s George Methlie School. Her first assignment at IARPA was from 2013-2015 as the deputy\ndirector. Dr. Marsh joined the CIA in 2001 and served in serval capacitates to innovate power solutions for the intelligence community. While in industry\, she led the team that put lithium-ion technology on numerous platforms\, including NASA’s MARS exploration rovers Spirit and Opportunity. Dr. Marsh is a director of the National Intelligence Fellow and member of the DS&T’s distinguished expert cadre. She holds a bachelor’s and doctorate in inorganic and analytic\nchemistry from Brown University \nLTC Thomas Pike\, Ph.D. / National Intelligence University\, IC Educator of the Year Awardee\nLTC Tom Pike is faculty at the National Intelligence University and Technical Director of the Center for Anticipatory Intelligence and Adaptive Influence. He earned his PhD in Computational Social Science from George Mason University. His primary research interest is the collective intelligence of complex systems at the organizational and societal level. He has done research on multi-leveled networks and civil conflict. \nBrian T. Holmes\, Ph.D. / Dean\, National Intelligence University School of Science and Technology Intelligence\nDr. Holmes is the Dean of the School of Science and Technology Intelligence at the National Intelligence University in Bethesda\, MD. The School is the focus for science and technical analytic education\, research and external engagement across the intelligence and national security communities. He joined the University in 2012 to complement the existing members of the School and enable its burgeoning mission. The National Intelligence University was chartered by the Department of Defense in 1962\, and the University’s degrees — the Master of Science of Strategic Intelligence\, the Master of Science and Technology Intelligence\, and the Bachelor of Science in Intelligence — are authorized by Congress. The University is managed by the Defense Intelligence Agency (DIA)\, and receives strategic guidance from the Director of National Intelligence (DNI). From 2012-2016\, Dr. Holmes chaired the Emerging and Disruptive Technology\, Geostrategic Resources and Environment\, and Weapons of Mass Destruction concentrations in the School. He serves as an executive representative to the Scientific and Technical Intelligence Committee under the auspices of the National Intelligence Council\, and directly supports Intelligence Community Directive 204 (National Intelligence Priorities Framework). He primarily focuses his research on dual use technologies\, and the translation of emerging research and development into advanced materials for military systems. From 2016-2017\, Dr. Holmes served as the Associate Dean of the School of Science and Technology Intelligence.
URL:https://globalbiodefense.com/event/7th-annual-intelligence-community-academic-research-program/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/intelligence-community-academic-research-icars.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211003T080000
DTEND;TZID=America/Los_Angeles:20211003T170000
DTSTAMP:20211004T003833Z
CREATED:20211004T003833Z
LAST-MODIFIED:20211004T003833Z
UID:50029-1633248000-1633280400@globalbiodefense.com
SUMMARY:Book Event: To End a Plague: America’s Fight to Defeat AIDS in Africa - Emily Bass
DESCRIPTION:CSIS Global Health Policy Center will host a virtual event featuring Emily Bass\, veteran AIDS activist\, historian and journalist\, and author of  To End a Plague: America’s Fight to Defeat AIDS in Africa on Oct 13 from 1:00 p.m. to 2:00 p.m. EDT. \nShe’ll be joined in conversation by Jennifer Kates\, Senior Vice President and Director of Global Health & HIV Policy at KFF; Chris Collins\, President & CEO at Friends of the Global Fight Against AIDS\, Tuberculosis and Malaria; and Ben Plumley\, Senior Advisor at Bay Area Global Health Alliance & Host of A Shot In The Arm and newly launched Vax Up Podcast. Jeffrey L. Sturchio\, CSIS Global Health Policy Center Senior Associate (Non-resident)\, will moderate the discussion. \nTo End a Plague chronicles the transnational activism\, legislative deal-making and unprecedented political leadership that led to President George W. Bush’s 2003 announcement of a program known as the U. S. President’s Emergency Program for AIDS Relief (PEPFAR). Today\, PEPFAR is America’s most successful long-term pandemic-fighting program. With more than $85 billion invested\, 18.2 million men\, women\, and children treated with antiretroviral therapy\, and more than 50 million people provided HIV prevention services in recent years\, it is also the largest commitment by any nation to address a single disease in history. At a time when the world—and the American government—is grappling with how to fund and fight the global Covid-19 pandemic\, this panel will reflect on the lessons learned from PEPFAR\, the crucial contributions by people living with HIV and their allies\, and the crucial factors behind this program’s improbable and long-standing bipartisan support. \nThis event is made possible by the generous support of the Bill & Melinda Gates Foundation.  \nPlease visit the CSIS Emily Bass Book Event website to register.
URL:https://globalbiodefense.com/event/book-event-to-end-a-plague-americas-fight-to-defeat-aids-in-africa-emily-bass/
CATEGORIES:Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=JVE7UZkoO6U
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211005T120000
DTEND;TZID=America/New_York:20211005T133000
DTSTAMP:20210925T154350Z
CREATED:20210925T154304Z
LAST-MODIFIED:20210925T154350Z
UID:49825-1633435200-1633440600@globalbiodefense.com
SUMMARY:Complications of COVID-19
DESCRIPTION:Dr. Colleen Kraft\, ASM President Elect\, leads an in-depth discussion on how vaccination and therapeutics have been used to address the long-term complications of COVID-19. \nThis free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS)\, one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics around COVID-19. \nABOUT THE SPEAKER \nColleen Kraft\, M.D.\, M.Sc.\, completed residency in Internal Medicine and fellowship in Infectious Diseases in the Department of Medicine\, Emory University\, as well as a Masters in Clinical Research. She pursued post-graduate training in an ACGME-accredited Medical Microbiology fellowship. She ia a Medical Director of the Microbiology section for Emory Medical Laboratories at Emory Healthcare\, as well as program director of the Medical Microbiology fellowship. She is an Associate Professor in the Department of Pathology and Laboratory Medicine and the Division of Infectious Diseases and serves as the associate chief medical officer of Emory University hospital. She rounds on the inpatient infectious diseases consult service so to link clinical microbiology to the bedside. Her research interests are in next-generation sequencing\, microbiome therapeutics\, and healthcare innovation factors. She is very passionate about mentorship of trainees and training the next generation. She believes that creativity and innovation in federal policy can bring about lasting positive change in science. \nThis virtual event is open to ASM members and non-members. Registration opens Tuesday\, Sept. 28\, 2021.
URL:https://globalbiodefense.com/event/complications-of-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211005T120000
DTEND;TZID=America/New_York:20211005T153000
DTSTAMP:20210924T193824Z
CREATED:20210924T193720Z
LAST-MODIFIED:20210924T193824Z
UID:49771-1633435200-1633447800@globalbiodefense.com
SUMMARY:Improving Diversity of the Genomics Workforce: A Workshop
DESCRIPTION:The Roundtable on Genomics and Precision Health will host a virtual public workshop that will examine the current state of diversity (e.g.\, racial\, ethnic) of the genetics and genomics workforce\, structural issues that have contributed to diversity challenges\, and potential steps forward. Workshop discussions may address topics such as the impact of racism on the culture of the fields of genetics and genomics; how the genetics/genomics workforce is or is not uniquely affected by structural racism; and the relationship between the lack of diversity in the workforce and patient access to genetic services. \nPanelists will be asked to discuss structural challenges impeding workforce diversity in clinical genetics/genomics\, current efforts to improve workforce diversity in the field\, how those efforts might improve access for patients from underrepresented groups\, and opportunities for professional societies and associations to better support the training and integration of providers from diverse backgrounds. A proceedings in brief of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \nBACKGROUND \nThe sequencing of the human genome is rapidly opening new doors to research and progress in biology\, medicine\, and health care. At the same time\, these developments have produced a diversity of new issues to be addressed. The National Academies of Sciences\, Engineering\, and Medicine has convened a Roundtable on Genomics and Precision Health (previously the Roundtable on Translating Genomic-Based Research for Health) that brings together leaders from academia\, industry\, government\, foundations and associations\, and representatives of patient and consumer interests who have a mutual concern and interest in addressing the issues surrounding the translation of genome- based research for use in maintaining and improving health. The mission of the Roundtable is to advance the field of genomics and improve the translation of research findings to health care\, education\, and policy. \nThe Roundtable will discuss the translation process\, identify challenges at various points in the process\, and discuss approaches to address those challenges. The field of genomics and its translation involves many disciplines\, and takes place within different economic\, social\, and cultural contexts\, necessitating a need for increased communication and understanding across these fields. As a convening mechanism for interested parties from diverse perspectives to meet and discuss complex issues of mutual concern in a neutral setting\, the Roundtable: fosters dialogue across sectors and institutions; illuminates issues\, but does not necessarily resolve them; and fosters collaboration among stakeholders. To achieve its objectives\, the Roundtable conducts structured discussions\, workshops\, and symposia. Workshop summaries will be published and collaborative efforts among members are encouraged (e.g.\, journal articles). \nSpecific issues and agenda topics are determined by the Roundtable membership\, and span a broad range of issues relevant to the translation process. Issues may include the integration and coordination of genomic information into health care and public health including encompassing standards for genetic screening and testing\, improving information technology for use in clinical decision making\, ensuring access while protecting privacy\, and using genomic information to reduce health disparities. The patient and family perspective on the use of genomic information for translation includes social and behavioral issues for target populations. There are\nevolving requirements for the health professional community\, and the need to be able to understand and responsibly apply genomics to medicine and public health. \nOf increasing importance is the need to identify the economic implications of using genome-based research for health. Such issues include incentives\, cost-effectiveness\, and sustainability. \nIssues related to the developing science base are also important in the translation process. Such issues could include studies of gene-environment interactions\, as well as the implications of genomics for complex disorders such as addiction\, mental illness\, and chronic diseases. \nLinks to Additional Resources \n\nBonham & Green\, 2021. The genomics workforce must become more diverse: a strategic imperative. The American Journal of Human Genetics 108(1): 3-7.\nChannaoui et al. 2020. Summary report of the 2019 Diversity and Inclusion Task Force of the National Society of Genetic Counselors. Journal of Genetic Counseling 29(2):192-201.\nMann\, S. 2020. Creation of the Minority Genetic Professionals Network to increase diversity in the genetics work force.\nRotenstein et al. 2021. Addressing workforce diversity – A quality-improvement framework. The New England Journal of Medicine. 384: 1083-1086.\nASHG 2021 Meeting- Session on workforce diversity in genomics: Equity and the meaning of inclusion.
URL:https://globalbiodefense.com/event/improving-diversity-of-the-genomics-workforce-a-workshop/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T150000
DTEND;TZID=America/New_York:20211006T170000
DTSTAMP:20210924T211020Z
CREATED:20210924T211020Z
LAST-MODIFIED:20210924T211020Z
UID:49774-1633532400-1633539600@globalbiodefense.com
SUMMARY:Respiratory Protection for the Public and Workers without Respiratory Protection Programs at their Workplaces
DESCRIPTION:This is the eighth virtual meeting of a consensus study focused on respiratory protection for the public and workers without respiratory protection programs. During the public portion of this meeting\, the committee will explore current processes and systems for evaluating infectious agents transmissible by inhalation routes and determining the need for public use of respiratory protective devices. \nThe discussion will be led by: \n\nJONATHAN SAMET\, Committee Chair Dean and Professor\, Colorado School of Public Health\nCAPT LISA DELANEY\, Associate Director\, Emergency Preparedness and Response Program\, National Institute for Occupational Safety and Health\nMICHAEL BELL\, Deputy Director\, Division of Healthcare Quality Promotion\, Centers for Disease Control and Prevention\n\nLearn more at NASEM’s Respiratory Protection for the Public and Workers without Respiratory Protection Programs at their Workplaces meeting page. \n 
URL:https://globalbiodefense.com/event/respiratory-protection-for-the-public-and-workers-without-respiratory-protection-programs-at-their-workplaces/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211007T094500
DTEND;TZID=America/New_York:20211007T140000
DTSTAMP:20210925T035750Z
CREATED:20210925T035750Z
LAST-MODIFIED:20210925T035750Z
UID:49811-1633599900-1633615200@globalbiodefense.com
SUMMARY:COVID-19 Vaccines: A Global Experts' Summit
DESCRIPTION:Hear from researchers and public health experts on present and future scenarios as they explore the changing landscape of the virus\, including the Delta variant’s impact on children\, and the latest in vaccine availability\, hesitancy and boosters. \nThis is the last in a series of three virtual events\, hosted by Florida International University in partnership with Baylor College of Medicine\, focusing on the most prevailing issues around COVID-19 and the challenges to preserve global health. \nPlease visit the COVID-19 Vaccines: A Global Experts’ Summit website for more information.
URL:https://globalbiodefense.com/event/covid-19-vaccines-a-global-experts-summit/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211007T183000
DTEND;TZID=Europe/London:20211007T193000
DTSTAMP:20210925T034618Z
CREATED:20210925T034618Z
LAST-MODIFIED:20210925T034618Z
UID:49808-1633631400-1633635000@globalbiodefense.com
SUMMARY:Poxvirus Research After Smallpox Eradication: New Findings With An Old Vaccine
DESCRIPTION:In 1980 smallpox was declared eradicated after a global vaccination campaign. Today\, only two labs in the world retain variola virus\, the cause of smallpox\, one in the USA and one in Russia – and the World Health Assembly has recommended these virus stocks be destroyed when essential research with variola virus is complete. \nProfessor Geoffrey L. Smith FRS\, winner of the 2020 Leeuwenhoek Medal\, will describe how smallpox was eradicated and what happened afterwards. Despite eradication\, research with vaccinia virus\, the smallpox vaccine\, has endured. This research has provided new ways to make vaccines\, and revealed how our cells respond to virus infection and how the virus escapes these defenses. \nAttending this event\nThis lecture was originally scheduled for March 2020 and has now been rescheduled to take place online. \nLearn more about the Poxvirus Research After Smallpox Eradication: New Findings With An Old Vaccine lecture at The Royal Society website. Register for this event on Eventbrite.
URL:https://globalbiodefense.com/event/poxvirus-research-after-smallpox-eradication-new-findings-with-an-old-vaccine/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211013T173000
DTEND;TZID=America/New_York:20211013T183000
DTSTAMP:20210930T222721Z
CREATED:20210930T215922Z
LAST-MODIFIED:20210930T222721Z
UID:49957-1634146200-1634149800@globalbiodefense.com
SUMMARY:The Future of Global Health Security
DESCRIPTION:Join faculty members from the Schar School’s Biodefense master’s program in a discussion on the future of global health security considering lessons learned from the COVID-19 pandemic. \nPolicy Exchange: The Future of Global Health Security will take place Wednesday\, October 13\, 2021 at 5:30 p.m. ET in a virtual format. This event highlights faculty from GMU Schar School’s Master’s in Biodefense program\, but all prospective students are invited to attend. \nThe COVID-19 pandemic revealed unexpected weaknesses in our preparedness for pandemic threats\, and it continues to pose serious challenges around the world. How are health authorities in the United States and around the world trying to reduce these vulnerabilities so we are better equipped for the next pandemic? \nABOUT THE PANEL \nAdjunct Professor Ashley Grant\, a lead biotechnologist at the MITRE Corporation\, previously served as the senior biological scientist at the Government Accountability Office where she led government-wide technical performance audits focused on biosafety and biosecurity issues. She was an American Association for the Advancement of Science (AAAS) Science and Technology Fellow in the Chemical and Biological Defense Program Office in the Department of Defense and worked at the National Academies of Science on the Committee on International Security and Arms Control. \nAdjunct Professor Andrew Kilianski is the chief intelligence officer for the Department of Defense’s Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense (JPEO-CBRND). His work focuses on combating weapons of mass destruction and infectious diseases\, counterintelligence threats to the DoD’s Chemical and Biological Defense Program\, and emerging threat characterization and assessment. Previously\, he served as the CBRN Defense Team Lead at the Defense Intelligence Agency – National Center for Medical Intelligence where he led a team of analysts covering worldwide WMD and medical science and technology developments. \nTerm Assistant Professor Saskia Popescu recently created and disseminated a gap analysis for a six-hospital system to establish vulnerabilities for high-consequence diseases\, helping to guide the creation of a high-consequence disease initiative to enhance readiness at the health care level. This work aided in rapid and coordinated responses to COVID-19. Popescu is certified in infection prevention (CIC)\, hospital preparedness through FEMA’s NIMS\, and pandemic preparedness from the DHS Center for Domestic Preparedness. She currently serves as a member of the Federation of American Scientists (FAS) Coronavirus Taskforce and is a member of the Committee on Data Needs to Monitor Evolution of SARS-CoV-2 within the Health and Medicine Division of the National Academies of Sciences\, Engineering\, and Medicine (NASEM). \nPlease visit the Schar School’s Policy Exchange: The Future of Global Health Security page for more information.
URL:https://globalbiodefense.com/event/gmu-biodefense-future-of-global-health-security-2/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/09/gmu-biodefense-future-global-health-security-event-banner-lg.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211014
DTEND;VALUE=DATE:20211016
DTSTAMP:20211004T005916Z
CREATED:20211004T005916Z
LAST-MODIFIED:20211004T005916Z
UID:50034-1634169600-1634342399@globalbiodefense.com
SUMMARY:VRBPAC Meeting on Janssen and Moderna COVID-19 Vaccine Boosters
DESCRIPTION:On Oct. 14 and 15\, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet to discuss the use of booster doses of the Moderna COVID-19 Vaccine and the Janssen COVID-19 Vaccine. Both vaccines are currently authorized for emergency use to prevent COVID-19 in individuals 18 years of age and older. The committee will also hear presentations and discuss the available data on the use of a booster of a different vaccine than the one used for the primary series of an authorized or approved COVID-19 vaccine (heterologous or “mix and match” booster). \nOn Oct. 14\, the committee will discuss an amendment to the emergency use authorization of the Moderna COVID-19 Vaccine for the administration of a booster dose\, in individuals 18 years of age and older. \nOn Oct. 15\, the VRBPAC will discuss amending the emergency use authorization of Johnson and Johnson’s Janssen COVID-19 Vaccine for the administration of a booster dose\, in individuals 18 years of age and older. \nAdditionally\, on Oct. 15\, the committee will hear a presentation from the National Institute of Health’s National Institute of Allergy and Infectious Diseases on the heterologous use of booster doses following the primary series of the three currently authorized or approved COVID-19 vaccines. \nDuring the meeting\, the committee will hear presentations from the companies on the data for their respective vaccines. The FDA will also present its own analyses of each of the manufacturers’ data. There will be an open public hearing each day during which the public will be given an opportunity to provide comments. \nThe FDA intends to make background materials for both VRBPAC meetings available to the public\, including the meeting agendas and committee rosters\, no later than two business days before each meeting. \nThe FDA intends to livestream the VRBPAC meetings on the agency’s YouTube page.
URL:https://globalbiodefense.com/event/vrbpac-meeting-on-janssen-and-moderna-covid-19-vaccine-boosters/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/10/fda-vrbpac-mix-match-booster-shots-janssen-moderna-boosters-covid-19.jpg
LOCATION:https://www.youtube.com/watch?v=BhlshZ7Lkr0
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211014T110000
DTEND;TZID=America/New_York:20211014T120000
DTSTAMP:20210924T211921Z
CREATED:20210924T211756Z
LAST-MODIFIED:20210924T211921Z
UID:49776-1634209200-1634212800@globalbiodefense.com
SUMMARY:Protecting Health Care in Zones of Conflict: A Webinar
DESCRIPTION:Panelists Leonard Rubenstein (author of the recently released Perilous Medicine: The Struggle to Protect Health Care from the Violence of War) and Joanne Liu will discuss attacks on health workers\, patients\, and hospitals in conflict settings around the world\, along with urgent actions that need to be taken to help ensure safe access to and delivery of health care. The discussion will be moderated by Robert Lawrence. \nSpeakers: \nJoanne Liu\, Professor at the School of Population and Global Health\, McGill University and former International President\, Me´decins Sans Frontie`res \nDr. Joanne Liu has served as International President of Médecins Sans Frontières (MSF) from 2013 to 2019. At the helm of MSF\, she has been a leading voice on medical humanitarian crises\, namely in the Ebola outbreak of West Africa and attacks on hospitals and forced displacement crises\, and has engaged with world leaders at the highest levels. Dr. Liu’s role builds on a career of field work with MSF\, including over 20 medical-humanitarian field assignments. Dr. Liu trained at McGill University School of Medicine in Montreal. She holds a Fellowship in Pediatric Emergency Medicine from New York University School of Medicine and an International Master’s in Health Leadership\, also from McGill University. Dr. Liu’s operational work has ranged from introducing comprehensive care for survivors of sexual violence\, to developing a telemedicine platform for connecting doctors in rural areas with specialists worldwide. Dr. Liu remains a practicing doctor\, both in the field with MSF and also through hospital shifts in her home town of Montreal. She is currently a Professor at the School of Population and Global Health at McGill University with a focus on pandemic preparedness and response and health emergencies. \nLeonard Rubenstein\, Professor of the Practice\, Johns Hopkins Bloomberg School of Public Health \nProf. Leonard Rubenstein is Professor of the Practice at the Johns Hopkins Bloomberg School of Public Health\, and Director of the Program in Human Rights\, Health and Conflict. He is also a core faculty member the Berman\nInstitute of Bioethics and the Center for Humanitarian Health at Johns Hopkins University. Prior to coming to Johns Hopkins in 2009\, he was a Jennings Randolph Senior Fellow at the United States Institute of Peace\, and\nbefore that Executive Director and then President of Physicians for Human Rights. He has a J.D. from Harvard Law School and LL.M. from Georgetown Law School. He is a member of the Council on Foreign Relations. He is the recipient of numerous awards\, including the Congressional Minority Caucuses’ Healthcare Hero Award and the Sidel-Levy Award for Peace of the American Public Health Association. He has appeared before Congress\, the World Health Assembly and the UN Security Council. \nRobert Lawrence (Moderator)\, Center for a Livable Future Professor Emeritus\, John Hopkins Bloomberg School of Public Health and member of the National Academy of Medicine \nRobert Lawrence is the Center for a Livable Future Professor Emeritus and Professor Emeritus of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health and Professor Emeritus of\nMedicine at the Johns Hopkins School of Medicine. Dr. Lawrence graduated from Harvard Medical School\, trained in Internal Medicine at the Massachusetts General Hospital in Boston\, and served for three years as an Epidemic Intelligence Service Officer\, Centers for Disease Control and Prevention. At the University of North Carolina and as director of the Division of Primary Care at Harvard Medical School and chief of Medicine at the Cambridge Hospital\, he helped develop community health service and training programs. \nDr. Lawrence chaired the first U.S. Preventive Services Task Force from 1984-89 and served on the successor Task Force from 1990-96. From 1991 to 1995\, he served as Director of Health Sciences at the Rockefeller Foundation. He served as associate dean for professional education and programs at JHBSPH from 1995-2006\, established the Center for a Livable Future in 1996\, and served as its director until 2015. As a founding member of Physicians for Human Rights and former member of the Board of Directors\, Dr. Lawrence has participated in human rights investigations on behalf of PHR or other human rights groups to Chile\, Czechoslovakia\, Egypt\, El Salvador\, Guatemala\, the Philippines\, South Africa\, and Kosovo. He is a member of the National Academy of Medicine of the National Academy of Sciences \nPlease visit NASEM’s Protecting Health Care in Zones of Conflict: A Webinar project page for more information. Register on Eventbrite here.
URL:https://globalbiodefense.com/event/protecting-health-care-in-zones-of-conflict-a-webinar/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211019T120000
DTEND;TZID=America/New_York:20211019T133000
DTSTAMP:20210925T154740Z
CREATED:20210925T154620Z
LAST-MODIFIED:20210925T154740Z
UID:49829-1634644800-1634650200@globalbiodefense.com
SUMMARY:Opportunities & Challenges for Next Generation Sequencing of SARS-CoV-2
DESCRIPTION:Dr. Natalie Prystajecky explores how the various public health applications of sequencing has played a crucial role in outbreak response\, surveillance\, emerging variant detection\, and more during the COVID-19 pandemic. \nThis free event is brought to you by the 2021 ASM Clinical Virology Symposium (CVS)\, one of a 4-part CVS Online: SARS-CoV-2 Webinar Series featuring leading experts in the field discussing the most pressing topics around COVID-19. \nABOUT THE SPEAKER \nNatalie Prystajecky\, Ph.D.\nBCCDC Public Health Laboratory \nNatalie Prystajecky\, Ph.D. is a microbiologist at the British Columbia CDC Public Health Laboratory (BCCDC PHL)\, where she oversees the Environmental Microbiology and the Molecular and Microbial Genomics laboratories. She is also Clinical Associate Professor in Pathology and Laboratory Medicine at the University of British Columbia. \nIn her clinical roles and research endeavours\, she uses emerging technologies\, such as genomics\, to improve routine surveillance and outbreak investigations. During the COVID-19 pandemic\, she has provided leadership at the BCCDC PHL to implement genomics and explore opportunities and challenges for next generation sequencing of SARS-CoV-2. \nThis virtual event is open to ASM members and non-members. Registration opens Tuesday\, Sept. 28\, 2021.
URL:https://globalbiodefense.com/event/opportunities-challenges-for-next-generation-sequencing-of-sars-cov-2/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
END:VCALENDAR